Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DENECOR

Financiado

Devices for Neurocontrol and Neurorehabilitation

The primary aim of DeNeCor is to resolve this top issue such that electronic neuromodulation therapy becomes mainstream and full market potential can be obtained. We will increase acceptance by neurologists by demonstrating design... ver más

31/03/2016

PHILIPS MEDICAL SY...

20M€

Presupuesto del proyecto: 20M€

Líder del proyecto

PHILIPS MEDICAL SYSTEMS NEDERLAND BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 15 Participantes

Financiación concedida El organismo FP6 notifico la concesión del proyecto el día 2016-03-31 No tenemos la información de la convocatoria

0% 100%

15 Participantes

PHILIPS MEDICAL SYSTEMS NEDE...

Lider

G TEC MEDICAL ENGINEERING SP...

N.D. | Participante

LEITAT

N.D. | Participante

AIT

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PCIN-2013-050 DISPOSITIVOS PARA CONTROL NEURONAL Y REHABILITACION 110K€ Cerrado

PCIN-2013-175 DISPOSITIVOS PARA CONTROL NEURONAL Y REHABILITACION 39K€ Cerrado

INcEPTION Induction of NEuromuscular Plasticity for natural motor reha... 2M€ Cerrado

PID2020-113222RB-C22 DESARROLLO Y VALIDACION CLINICA DE UNA PLATAFORMA BASADA EN... 105K€ Cerrado

PID2021-128611OB-I00 DESARROLLO DE SISTEMAS NERVIO-EN-UN-CHIP PARA EVALUAR EL EFE... 151K€ Cerrado

DPI2015-68664-C4-1-R DESARROLLO Y VALIDACION CLINICA DE UNA PLATAFORMA DE REHABIL... 230K€ Cerrado

Duración del proyecto: 33 meses Fecha Inicio: 2013-06-01
Fecha Fin: 2016-03-31

Líder del proyecto

PHILIPS MEDICAL SYSTEMS NEDERLAND BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 20M€

Descripción del proyecto The primary aim of DeNeCor is to resolve this top issue such that electronic neuromodulation therapy becomes mainstream and full market potential can be obtained. We will increase acceptance by neurologists by demonstrating designed co-existency between therapy devices and diagnostic systems. The second aim of DeNeCor is to extrapolate the ‘bilateral’ agreements between AIMD and MRI manufactures in IEC/ISO 10974 to other diagnostic systems and the interaction between diagnostic systems, like EEG and UltraSound (US) and non-invasive electronics based neuromodulation therapies (paving the way for image guided neuromodulation therapy). Also in this case technical challenges have to be solved. In particular DeNeCor targets:• Focused spatial localization with a transcranial magnetic stimulator (TMS), which requires the design of a coil array with compact distributed power electronic modules and control electronics;• Arrays for neural sensing, invasive and non-invasive, based on new sensor arrays and packaging technology, with connection to modulation and rehabilitation devices. • Replacing piezo-electric US transducers by Capacitive Micromachined Ultrasound Transducers (CMUT) including 3D packaging, ASIC development and integration in an endoscopic systemThe third aim of DeNeCor is to develop test methods such that the development of therapy devices and diagnostic systems can be decoupled which increases the efficiency of the demonstrator developments and enables technical evolution of all systems at their own pace. In addition test methods are currently missing from the Technical Specification IEC/ISO 10974 and are essential for its transformation in to an international safety standard.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores